Healthcare Services

Chronic Venous Occlusions Treatment Market Future Outlook Showing Expansion Toward $10.07 Billion by 2030

March 31, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Chronic Venous Occlusions Treatment Market Over The Period 2026–2030?

The chronic venous occlusions treatment market size has experienced robust growth in recent years. It is anticipated to expand from $7.15 billion in 2025 to $7.6 billion in 2026, registering a compound annual growth rate (CAGR) of 6.3%. The market’s historical growth can be attributed to the increasing prevalence of venous disorders, the wider availability of endovascular treatment options, a rise in hospital-based interventional procedures, heightened awareness of chronic venous diseases, and the expanded use of anticoagulant therapies.

The chronic venous occlusions treatment market size is projected to experience substantial growth over the next few years. It is forecast to reach $10.08 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. The expansion anticipated during the forecast period is attributable to an increasing aging population base, rising demand for outpatient venous procedures, a growing focus on early disease diagnosis, the expansion of advanced imaging-assisted treatments, and an increasing adoption of next-generation venous devices. Key trends for the forecast period include the increasing adoption of minimally invasive venous interventions, the rising use of advanced venous stenting technologies, a growing preference for combination device and drug therapies, the expansion of image-guided endovascular procedures, and an enhanced focus on long-term occlusion management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13286&type=smp

Which Economic Or Industry Drivers Are Impacting The Chronic Venous Occlusions Treatment Market?

A rising occurrence of obesity is projected to drive expansion within the chronic venous occlusion treatment market in the future. Obesity defines a health state marked by an excessive build-up of body fat, generally leading to an individual having a body mass index (BMI) of 30 or higher. Chronic venous occlusion treatment can aid in managing symptoms linked to obesity, such as edema and changes in skin, through enhanced blood circulation and decreased inflammation, thereby assisting in more effective obesity control. As an illustration, data from March 2023, provided by the World Heart Federation, a non-governmental global cardiovascular organization located in Switzerland, indicated that approximately 2.3 billion adults and children worldwide were classified as obese or overweight. Furthermore, based on current obesity trajectories, projections suggest that the population affected by obesity will escalate to 2.7 billion by 2025. Consequently, the increasing prevalence of obesity is fueling the expansion of the chronic venous occlusion treatment market.

How Is The Chronic Venous Occlusions Treatment Market Divided Into Its Major Segments?

The chronic venous occlusions treatment market covered in this report is segmented –

1) By Product: Devices, Drugs

2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications

3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users

Subsegments:

1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons

2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs

What Trends Are Projected To Affect The Chronic Venous Occlusions Treatment Market?

Leading firms within the chronic venous occlusion treatment market are concentrating on creating cutting-edge solutions, including implantable medical devices designed to address symptomatic venous outflow obstruction in individuals suffering from chronic venous insufficiency (CVI). Such a device is surgically inserted and intended to stay within the body for a prolonged duration, frequently serving to diagnose, manage, or observe various medical ailments. For example, in June 2024, Koninklijke Philips N.V. (Philips), a technology firm based in the Netherlands, introduced the Duo Venous Stent System, which is an implantable medical device. Koninklijke Philips N.V.’s Duo Venous Stent System incorporates a dual-layer structure, boosting its flexibility and radial strength to provide superior vein support. Additionally, its sophisticated coating improves its compatibility with biological systems and reduces the likelihood of thrombosis, while a highly accurate delivery mechanism guarantees precise positioning even in complex anatomical areas.

Who Are The Prominent Organizations Shaping The Chronic Venous Occlusions Treatment Market?

Major companies operating in the chronic venous occlusions treatment market are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA

Read the full chronic venous occlusions treatment market report here:

https://www.thebusinessresearchcompany.com/report/chronic-venous-occlusions-treatment-global-market-report

What Are The Top-Performing Regions Within The Chronic Venous Occlusions Treatment Market?

North America was the largest region in the chronic venous occlusions treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Venous Occlusions Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13286&type=smp

Browse Through More Reports Similar to the Global Chronic Venous Occlusions Treatment Market 2026, By The Business Research Company

Allergic Rhinitis Global Market Report

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Dermatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Atopic Dermatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795